Serum MMP7, MMP10 and MMP12 level as negative prognostic markers in colon cancer patients

P31: The Relationship between Serum Substance P Level and the Type as well as Prognostic Factors in Patients with Stroke

Stroke is the world's largest neurological defect caused by the disruption of brain blood circulation. Apart from death, the severest damage caused by stroke, a plethora of other mental and physical disabilities can ensue the incidence of a stroke. As a result of the continued disruption of blood circulation triggered by a stroke, biochemical and physiological mechanisms affect nerve cells and ...

P53 and Ki-67 as prognostic markers in triple-negative breast cancer patients

Triple-negative breast cancer (TNBC) is an aggressive subgroup of breast cancer lack of effective target therapy. This study was to investigate the prognostic role of p53 and Ki-67 in 156 cases of TNBC patients. Logistic regression analysis was used to examine the association between clinical parameters and recurrence. Univariate and multivariate analyses were used to examine the association be...

Prognostic markers in triple-negative breast cancer.

BACKGROUND Triple-negative breast cancer (estrogen receptor-negative, progesterone receptor-negative, and HER2-negative) is a high risk breast cancer that lacks the benefit of specific therapy that targets these proteins. METHODS In this study, the authors examined a large and well characterized series of invasive breast carcinoma (n = 1944) with a long-term clinical follow-up (median, 56 mon...

Troponin Serum Level in Ischemic Stroke Patients and its Prognostic Value

Background: Some recent studies have shown that troponin may have a Prognostic value in patients with ischemic stroke. This study seeks to to evaluate the prognostic value of troponin on 3 months mortality and recurrence in patients with ischemic stroke. Method: In this study 63 patients with ischemic stroke were evaluated. Embolic and lacunar stroke were excl...

Soluble Intracellular Adhesion Molecule-1 in the Serum of Colon and Gastric Cancer Patients